Microbot Medical Ownership
| MBOT Stock | USD 1.66 0.01 0.60% |
Shares in Circulation | First Issued 1991-03-31 | Previous Quarter 14.8 M | Current Value 16.5 M | Avarage Shares Outstanding 1.6 M | Quarterly Volatility 3.4 M |
Microbot |
Microbot Stock Ownership Analysis
The company recorded a loss per share of 0.79. Microbot Medical last dividend was issued on the 5th of September 2018. The entity had 1:15 split on the 5th of September 2018. Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. Microbot Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 20 people. To find out more about Microbot Medical contact Harel Gadot at 781 875 3605 or learn more at https://microbotmedical.com.Besides selling stocks to institutional investors, Microbot Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Microbot Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Microbot Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Microbot Medical Quarterly Liabilities And Stockholders Equity |
|
Only 1.62% of Microbot Medical are currently held by insiders. Unlike Microbot Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Microbot Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Microbot Medical's insider trades
Microbot Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Microbot Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Microbot Medical backward and forwards among themselves. Microbot Medical's institutional investor refers to the entity that pools money to purchase Microbot Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Securities, Llc | 2024-12-31 | 10.7 K | Stifel Financial Corp | 2024-12-31 | 10.3 K | Bb&t Corp. | 2024-12-31 | 10 K | Diamant Asset Management Inc | 2024-12-31 | 10 K | Wells Fargo & Co | 2024-12-31 | 8.9 K | Beacon Capital Management, Llc | 2024-12-31 | 6 K | Bfsg, Llc | 2024-12-31 | 5.5 K | Tower Research Capital Llc | 2024-12-31 | 4.4 K | Sbi Securities Co Ltd | 2024-12-31 | 3 K | Vanguard Group Inc | 2024-12-31 | 459.5 K | Geode Capital Management, Llc | 2024-12-31 | 142.7 K |
Microbot Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Microbot Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Microbot Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Microbot Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Microbot Medical Outstanding Bonds
Microbot Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Microbot Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Microbot bonds can be classified according to their maturity, which is the date when Microbot Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| US595017BA15 Corp BondUS595017BA15 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.